RxDoctor Payments Data

Jacob Hanlon, DPM

Foot & Ankle Surgery · Dover, DENPI 1831196831

Payments from drug & device makers

What this record shows

This record is dominated by other: $48,000 of the $49,717 with a category attached, or 96.5%. Convatec Inc. accounts for 96.6% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $48,028, more than ten times the $134 reported in 2019. Among foot & ankle surgery clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$49,717in general payments, 2019–2025

Across 17 payments — averaging $2924.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Convatec Inc.$48K
  • Supreme Orthopedic Systems, LLC$1K
  • Smith+Nephew$150
  • Arthrex$105
  • Medtronic$40
  • Heron Therapeutics, Inc.$28

What the payments were for

  • Food & beverage$5171%
  • Education$1,2002%
  • Other$48,00097%

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$49,717 in reported general payments places this provider in the 95th percentile of 32 foot & ankle surgery providers in Delaware.

See all foot & ankle surgery providers in Delaware

Medicare billing

Part B allowed, 2024
$682,807
Medicare patients
2,063
Services billed
11,020

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium169$2,267
Lidocaine24$2,245
Gabapentin133$2,242
Ciclopirox41$1,123
Meloxicam127$970
Cephalexin58$931
Ammonium Lactate19$853
Methylprednisolone147$786
Econazole Nitrate15$660
Ibuprofen40$498
Pregabalin31$390
Naproxen20$281
Doxycycline Hyclate26$280
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim37$218
Celecoxib20$209

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Dover

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →